Q2 2023 · 13F-HR
Birchview Capital, LPholdings as filed
Filed 2023-08-08 · accession 0001618205-23-000004
$133.4M
Reported value
54
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $46.6M | 34.9% | 728,585 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $10.7M | 7.99% | 156,111 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $7.9M | 5.95% | 84,240 | Common | SOLE |
| 09075X108 | — | BIODESIX INC | $6.2M | 4.65% | 5,039,633 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $6.0M | 4.48% | 249,400 | Common | SOLE |
| 74838J101 | — | QUIDELORTHO CORP | $5.4M | 4.05% | 65,203 | Common | SOLE |
| 05479K106 | ELUT | AZIYO BIOLOGICS INC | $3.9M | 2.93% | 1,655,184 | Common | SOLE |
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $3.6M | 2.69% | 190,000 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP | $3.3M | 2.48% | 15,000 | Common | SOLE |
| 69047Q102 | OVV | OVINTIV INC | $3.2M | 2.40% | 84,200 | Common | SOLE |
| 415858109 | HROW | HARROW HEALTH INC | $2.9M | 2.14% | 150,000 | Common | SOLE |
| 71944F106 | PHR | PHREESIA INC | $2.6M | 1.92% | 82,700 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $2.5M | 1.88% | 15,280 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $1.9M | 1.40% | 264,843 | Common | SOLE |
| 45720L107 | INBXUSD | INHIBRX INC | $1.8M | 1.37% | 70,448 | Common | SOLE |
| 00430H102 | — | ACCELERATE DIAGNOSTICS INC | $1.8M | 1.37% | 2,252,388 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $1.6M | 1.17% | 50,000 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HOLDINGS INC | $1.4M | 1.08% | 80,000 | Common | SOLE |
| 294600101 | ETRNUSD | EQUITRANS MIDSTREAM CORPORATIO | $1.3M | 0.95% | 133,050 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $1.1M | 0.83% | 50,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $1.1M | 0.82% | 12,000 | Common | SOLE |
| 834203101 | — | SOLENO THERAPEUTICS INC | $1.1M | 0.79% | 245,127 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $1.0M | 0.79% | 38,000 | Common | SOLE |
| 256086109 | DCGO | DOCGO INC | $1.0M | 0.77% | 110,000 | Common | SOLE |
| 46583P102 | — | IVERIC BIO INC | $983,500 | 0.74% | 25,000 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $903,550 | 0.68% | 85,000 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $865,920 | 0.65% | 26,400 | Common | SOLE |
| 09609G100 | — | BLUEBIRD BIO INC | $819,868 | 0.61% | 249,200 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $815,500 | 0.61% | 25,000 | Common | SOLE |
| 723787107 | PXDEUR | PIONEER NATURAL RESOURCES CO | $787,284 | 0.59% | 3,800 | Common | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC | $670,080 | 0.50% | 12,000 | Common | SOLE |
| 82710M100 | SILKUSD | SILK ROAD MEDICAL INC | $649,800 | 0.49% | 20,000 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $614,400 | 0.46% | 40,000 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $605,510 | 0.45% | 59,833 | Common | SOLE |
| 16961L106 | — | CHINOOK THERAPEUTICS INC | $576,300 | 0.43% | 15,000 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $521,484 | 0.39% | 291,332 | Common | SOLE |
| G5269C101 | — | KINIKSA PHARMACEUTICALS LTD | $422,400 | 0.32% | 30,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $385,000 | 0.29% | 10,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $372,300 | 0.28% | 15,000 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $365,200 | 0.27% | 40,000 | Common | SOLE |
| 40637H109 | HALO | HALOZYME THERAPEUTICS INC | $360,700 | 0.27% | 10,000 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $360,000 | 0.27% | 40,000 | Common | SOLE |
| 74340E103 | PGNY | PROGYNY INC | $354,060 | 0.27% | 9,000 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $351,680 | 0.26% | 28,000 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $307,131 | 0.23% | 12,300 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $286,300 | 0.21% | 2,500 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $281,260 | 0.21% | 7,000 | Common | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $270,227 | 0.20% | 25,114 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $223,000 | 0.17% | 50,000 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $140,800 | 0.11% | 20,000 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $118,906 | 0.09% | 99,088 | Common | SOLE |
| 3621LQ109 | GTHXEUR | G1 THERAPEUTICS INC | $99,600 | 0.07% | 40,000 | Common | SOLE |
| 98585K102 | — | YIELD10 BIOSCIENCE INC | $41,625 | 0.03% | 18,750 | Common | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $16,106 | 0.01% | 28,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.